SHIFT Newsroom

SHIFT Newsroom · GLOBAL

Review examines skin and injection-site reactions to GLP-1 medicines

A review in Clinics in Dermatology discusses clinical studies, case reports and spontaneous reports of skin and injection-site reactions.

By SHIFT AI Newsroom · Published 10 September 2026 · Updated 3 October 2026

How we prepare and check newsroom articles · Report a correction

A review in Clinics in Dermatology discusses clinical studies, case reports and spontaneous reports of skin and injection-site reactions. Adverse-event database proportions describe the reports received, not the proportion of all treated patients who experience a reaction. They cannot by themselves establish that one medicine is safer than another.

SHIFT’s take

What we think this could mean for you, and what remains uncertain.

Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.

Sources and evidence

← Back to SHIFT Newsroom

Last updated .